Hardly a month passes by without press reports of new wonder drugs offering glimmers of hope to patients with dementia. Unfortunately, most of these stories prove to be misleading: like […]
Latest articles
Frank Dobson on the opening of The Francis Crick Institute
The Francis Crick Institute for bio-medical research will open today. The present Government will claim credit for it. But the project is nearing completion only because of far-sighted decisions by […]
John King: Adapting to Brexit
As the shock of the referendum fades away, a deathly silence has come over the remain camp. The defeated remainers have gone to ground, while the process of leaving the […]
Wendy Reid: Postgraduate medical training in the NHS: complex and transforming
Junior doctors’ anger and disillusionment during their recent dispute highlight the need for a new approach to ensure that they feel valued and able to work in supportive and accountable […]
Elizabeth Loder: Should orange be the new black for price-gouging pharma execs?
One thing’s for sure: Heather Bresch, the CEO of Mylan Pharmaceuticals, looks good in orange. She’s the subject of a recent New York Times article that opens by declaring “America has […]
Nick Hopkinson: The burden of asthma—how to frame it and what needs to be done?
A study this week from the Asthma UK Centre for Applied Research at the University of Edinburgh, widely reported in the media, estimates that asthma costs the UK £1.1 billion/year […]
Claire McDaniel and Daniel Marchalik: Drawing a line in research
The Doctor’s Book Club Lily King’s Euphoria The woman is perfected. Her dead Body wears the smile of accomplishment, The illusion of a Greek necessity Flows in the scrolls of […]
Kawaldip Sehmi: Shopping around for the best system of universal health coverage
In September 2015, 194 member states of the United Nations agreed to adopt the resolution A/RES/70/1 from Transforming our world: the 2030 Agenda for Sustainable Development. By accepting this resolution they […]
Richard Smith: Making workplace health work after 40 years of failure
What is it that makes a company successful? Could it be strategy, leadership, funding, great products, luck, or something else? All of those things are secondary to the “essence” that […]
Richard Lehman’s journal review—30 August 2016
After a month’s break, I’m catching up with articles of interest in the main non-BMJ journals throughout August. Normal service will be resumed next week. NEJM Aug 2016 Vol 375 […]